1. Home
  2. MRVI vs FPF Comparison

MRVI vs FPF Comparison

Compare MRVI & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

SELL

Current Price

$6.80

Market Cap

1.2B

Sector

Health Care

ML Signal

SELL

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

SELL

Current Price

$15.79

Market Cap

965.7M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
MRVI
FPF
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
965.7M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
MRVI
FPF
Price
$6.80
$15.79
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $8.50
N/A
AVG Volume (30 Days)
★ 2.3M
291.2K
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
★ 8.08%
EPS Growth
★ 14.29
N/A
EPS
N/A
★ N/A
Revenue
★ $185,743,000.00
N/A
Revenue This Year
$14.01
N/A
Revenue Next Year
$6.20
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.55
$15.30
52 Week High
$9.42
$19.36

Technical Indicators

Market Signals
Indicator
MRVI
FPF
Relative Strength Index (RSI) 43.68 40.24
Support Level $6.49 N/A
Resistance Level $7.60 $15.99
Average True Range (ATR) 0.45 0.26
MACD -0.12 0.04
Stochastic Oscillator 17.71 57.69

Price Performance

Historical Comparison
MRVI
FPF

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: